BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 37051160)

  • 21. The prognostic value of aspartate aminotransferase-to-lymphocyte ratio index in early-stage hepatocellular carcinoma after hepatectomy: A propensity-score matched analysis.
    Chen Y; He C; Wen T; Yan L; Yang J
    Asia Pac J Clin Oncol; 2021 Oct; 17(5):e238-e248. PubMed ID: 33124200
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Pre- and Postoperative FIB-4 Indexes Are Good Predictors to the Outcomes of HBV-Related HCC Patients after Resection.
    Tsai MY; Yen YH; Huang PY; Sou FM; Lin CC; Cho WR; Wang HM; Chen DW; Chang KC; Wu CK; Hu TH; Tsai MC
    Gastroenterol Res Pract; 2019; 2019():8945798. PubMed ID: 31885547
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association Between Noninvasive Fibrosis Markers and Postoperative Mortality After Hepatectomy for Hepatocellular Carcinoma.
    Maegawa FB; Shehorn L; Aziz H; Kettelle J; Jie T; Riall TS
    JAMA Netw Open; 2019 Jan; 2(1):e187142. PubMed ID: 30657533
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Novel Inflammation-Based Prognostic Score: The Fibrinogen/Albumin Ratio Predicts Prognoses of Patients after Curative Resection for Hepatocellular Carcinoma.
    Xu Q; Yan Y; Gu S; Mao K; Zhang J; Huang P; Zhou Z; Chen Z; Zheng S; Liang J; Lin Z; Wang J; Yan J; Xiao Z
    J Immunol Res; 2018; 2018():4925498. PubMed ID: 30027102
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparisons of noninvasive indices based on daily practice parameters for predicting liver cirrhosis in chronic hepatitis B and hepatitis C patients in hospital and community populations.
    Tseng PL; Wang JH; Hung CH; Tung HD; Chen TM; Huang WS; Liu SL; Hu TH; Lee CM; Lu SN
    Kaohsiung J Med Sci; 2013 Jul; 29(7):385-95. PubMed ID: 23768703
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Noninvasive Tests for Fibrosis Predict 5-Year Mortality and Hepatocellular Carcinoma in Patients With Chronic Hepatitis B.
    Kim JH; Kim JW; Seo JW; Choe WH; Kwon SY
    J Clin Gastroenterol; 2016; 50(10):882-888. PubMed ID: 27322532
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Additional role of liver stiffness measurement in stratifying residual hepatocellular carcinoma risk predicted by serum biomarkers in chronic hepatitis B patients under antiviral therapy.
    Song BG; Sinn DH; Chi S; Kim K; Kang W; Gwak GY; Paik YH; Choi MS; Lee JH; Koh KC; Paik SW
    Eur J Gastroenterol Hepatol; 2018 Dec; 30(12):1447-1452. PubMed ID: 30063482
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel Models Predict Postsurgical Recurrence and Overall Survival for Patients with Hepatitis B Virus-Related Solitary Hepatocellular Carcinoma ≤10 cm and Without Portal Venous Tumor Thrombus.
    Wang XH; Liao B; Hu WJ; Tu CX; Xiang CL; Hao SH; Mao XH; Qiu XM; Yang XJ; Yue X; Kuang M; Peng BG; Li SQ
    Oncologist; 2020 Oct; 25(10):e1552-e1561. PubMed ID: 32663354
    [TBL] [Abstract][Full Text] [Related]  

  • 29. FIB-4 Index is a Predictor of Background Liver Fibrosis and Long-Term Outcomes After Curative Resection of Hepatocellular Carcinoma.
    Okamura Y; Ashida R; Yamamoto Y; Ito T; Sugiura T; Uesaka K
    Ann Surg Oncol; 2016 Aug; 23(Suppl 4):467-474. PubMed ID: 27364511
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Non-invasive tests for liver disease severity and the hepatocellular carcinoma risk in chronic hepatitis B patients with low-level viremia.
    Paik N; Sinn DH; Lee JH; Oh IS; Kim JH; Kang W; Gwak GY; Paik YH; Choi MS; Lee JH; Koh KC; Paik SW
    Liver Int; 2018 Jan; 38(1):68-75. PubMed ID: 28581248
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fibrosis-4, aspartate transaminase-to-platelet ratio index, and gamma-glutamyl transpeptidase-to-platelet ratio for risk assessment of hepatocellular carcinoma in chronic hepatitis B patients: comparison with liver biopsy.
    Kim MN; Lee JH; Chon YE; Ha Y; Hwang SG
    Eur J Gastroenterol Hepatol; 2020 Mar; 32(3):433-439. PubMed ID: 31490417
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predicting Liver Fibrosis in the Hepatitis C Population: Concordance Analysis Between Noninvasive Scoring Systems and Percutaneous Liver Biopsy.
    Mada PK; Malus ME; Saldaña Koppel DA; Adley S; Moore M; Alam MJ; Feldman M
    Cureus; 2020 Sep; 12(9):e10376. PubMed ID: 33062499
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Application of acoustic radiation force impulse elastography combined with serum markers in Child-Pugh grading.
    Wei L; Ye Z; Bao Z; Xu X; Lin X; Chen L
    Clinics (Sao Paulo); 2020; 75():e1670. PubMed ID: 32935822
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gamma-glutamyl transpeptidase-to-platelet ratio and the fibrosis-4 index in predicting hepatitis B virus-related hepatocellular carcinoma development in elderly chronic hepatitis B patients in China: A single-center retrospective study.
    Zhu YF; Tan YF; Xu X; Zheng JL; Zhang BH; Tang HR; Yang JY
    Medicine (Baltimore); 2019 Dec; 98(50):e18319. PubMed ID: 31852119
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of Non-invasive Fibrosis Markers in Predicting Esophageal Variceal Bleeding.
    Cifci S; Ekmen N
    Clin Endosc; 2021 Nov; 54(6):857-863. PubMed ID: 34034454
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Significance of platelet count and platelet-based models for hepatocellular carcinoma recurrence.
    Pang Q; Zhang JY; Xu XS; Song SD; Qu K; Chen W; Zhou YY; Miao RC; Liu SS; Dong YF; Liu C
    World J Gastroenterol; 2015 May; 21(18):5607-21. PubMed ID: 25987786
    [TBL] [Abstract][Full Text] [Related]  

  • 37. FIB-4 and APRI scores for predicting severe liver fibrosis in chronic hepatitis HCV patients: a monocentric retrospective study.
    Catanzaro R; Aleo A; Sciuto M; Zanoli L; Balakrishnan B; Marotta F
    Clin Exp Hepatol; 2021 Mar; 7(1):111-116. PubMed ID: 34027123
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The diagnostic value of non-invasive tests for the evaluation of liver fibrosis in chronic hepatitis B patients.
    Erdogan S; Dogan HO; Sezer S; Uysal S; Ozhamam E; Kayacetin S; Koca Y
    Scand J Clin Lab Invest; 2013; 73(4):300-8. PubMed ID: 23514016
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differences in the impact of prognostic factors for hepatocellular carcinoma over time.
    Toyoda H; Kumada T; Tada T; Yama T; Mizuno K; Sone Y; Maeda A; Kaneoka Y; Akita T; Tanaka J
    Cancer Sci; 2017 Dec; 108(12):2438-2444. PubMed ID: 28945309
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combination Of ALBI And APRI To Predict Post-Hepatectomy Liver Failure After Liver Resection For HBV-Related HCC Patients.
    Mai RY; Wang YY; Bai T; Chen J; Xiang BD; Wu GB; Wu FX; Li LQ; Ye JZ
    Cancer Manag Res; 2019; 11():8799-8806. PubMed ID: 31632139
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.